Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Biovation Limited

Biovation is a leading European protein engineering company specialising in antibody and protein engineering, with particular emphasis on antibody-based therapeutics. The Company is focused on the generation of antibodies and proteins which are non-immunogenic in man. The focus for protein therapeutics is the generation of clinically safe and effective molecules which are tolerated by the human immune system. Biovation's DeImmunisationTM technology has been successfully applied to generate over a dozen therapeutic antibodies ("DeImmunised antibodies") and has been the subject of eight corporate relationships to date. Biovation has also developed BiodisplayTM technology for the isolation of new antibodies from human antibody libraries. These antibodies are then subjected to DeImmunisation in order to generate therapeutic antibodies. The same human antibody libraries are being applied for proteomics in order to rapidly interrogate and profile proteins in human cells and tissues.


Contact Details:
Marischal College Broad Street
Aberdeen
Scotland
AB9 1AS
United Kingdom
Tel:44 1224 273197
Fax:44 1224 273198
Email:
WWW:

www.biovation.co.uk




Loading...

Recent Publications by Biovation Limited:

Identification and removal of a promiscuous CD4+ T cell epitope from the C1 domain of factor VIII.
BACKGROUND: The development of inhibitors in hemophiliacs is a severe...
20th August, 2005
Biovation J Thromb Haemost. 2005 May;3(5):991-1000.
DOI Direct Link
The development of a modified human IFN-alpha2b linked to the Fc portion of human IgG1 as a novel potential therapeutic for the treatment of hepatitis C virus infection.
Interferon-alpha (IFN-alpha), in conjunction with ribavirin, is the...
12th February, 2005
Biovation J Interferon Cytokine Res. 2004 Sep;24(9):560-72.
DOI Direct Link

Biovation Limited Patents:

US Patent No.Title
7264806 Modified anti-CD52 antibody
7125689 Method for rendering streptokinase less immunogenic to a human
6974699 Pharmaceuticals and assays using enzyme subunits
6927025 Methods for protein screening
6472365 Pharmaceuticals and assays using enzyme subunits

View more Biovation Limited patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 680 times since April 2007, the link to the organisation's website has been followed 140 times

Recent Search Terms used to find this page: biovation limited | Biovation limited | biovation limited | Biovation Limited | Biovation Limited | Biovation Limited | biovation | biovation limited | biovation | BIOVATION LIMITED | .

Search for more companies in Aberdeen

Search for more companies in Scotland



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Biovation Limited

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.